Company intelligence

GALT

Galectin Therapeutics Inc. · NASDAQ · Healthcare

Price$4.15+4.01% · +$0.16

Market cap273.31MEquity value

P / E-10.1Trailing ratio

Volume290.61KLatest session

Market data

GALT price chart

TradingView

Related signals

1 min delayed

Browse public GALT signals with their source context and measured market impact. Open any signal for its permanent analysis page.

GALTDec 20, 2024+2.30% since signal

Why Is Small Cap Galectin Therapeutics Stock Trading Lower On Friday?

Galectin's belapectin showed 43.2% varices reduction but lacked statistical significance. In a per-protocol analysis, varices reduction reached 48.9%, slightly below expectations. Full NAVIGATE trial data analysis is ongoing; updates expected in early 2025. GALT stock dropped 59% to $0.80 following the trial results.

View signal analysis

Research